Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients (AQUARIUS)

Clinical Trial ID NCT00853827

PubWeight™ 3.12‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00853827

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial. JAMA 2013 1.54
2 Renin-sensitive microRNAs correlate with atherosclerosis plaque progression. J Hum Hypertens 2013 0.79
3 Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial. J Am Heart Assoc 2013 0.79
4 Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS. Atherosclerosis 2015 0.78
Next 100